Certainty Korea 2026

Date: Thursday, June 18, 2026

Time: 9:30am – 4:25pm

Location: Seoul, Korea

Certainty by Certara provides valuable opportunities to connect you with industry leaders and modeling & simulation (M&S) experts. Certara’s experts and guest speakers present the latest regulatory updates, applied case studies, and the cutting-edge technologies including AI/ML related to Model-informed Drug Development, clinical pharmacology, Pharmacometrics, QSP, PBPK, and more.

We hope this annual event will help you connect with innovative researchers across various pharmaceutical companies and bring the innovations to your team.

Overview

Date & Time: 9:30am – 4:25pm, Thursday, June 18th
Reception desk opens at: 9:00am
Venue: Naru Seoul MGallery Ambassador, 2nd floor
Registration fee: Free of charge

Register now

Agenda

Speakers’ biography (PDF): Coming soon
Timetable with speaker information (PDF): Coming soon

Morning Sessions

Global MIDD Regulatory Landscape: FDA & EMA Updates

Modeling & Simulation approaches used for regulatory submissions

[Guest Speaker] Innovative Bispecific Translational Development: CT-P72 QSP case
Jongin Kim, DVM, PhD Director, New Drug Development, Celltrion

Strategy First: Translational modeling from preclinical to clinical - Case studies of FIH dose justification

Digital Data Flow (DDF) from 3D to 4D

Group photo & Lunch break & Demo booth

Afternoon Sessions

Enabling AI-driven Decision making from Discovery to Submissions Towards Increased Clinical Drug Candidate Success - Today and Future Vision

[Guest Speaker] (TBC) Data-driven License Out Success Stories

[Guest Speaker] Considerations for Non-Clinical Development from the Perspective of a Scientific Open Innovator
Sujin Ahn, PhD Executive Officer, Drug Metabolism and Pharmacokinetics (DMPK), Yuhan Corporation

Regulatory Gap Analysis in the Korean Market: Trends and Strategic Insight

Optimal dosing, optimal outcomes: PBPK case studies for ADCs